Targeting Toxoplasma gondii CPSF 3 as a new approach to control toxoplasmosis-Reference-Cited by-同舟云学术

Targeting Toxoplasma gondii CPSF 3 as a new approach to control toxoplasmosis

Published:2017-02 Issue:3 Volume:9 Page:385-394
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Palencia Andrés¹²^ORCID,Bougdour Alexandre¹^ORCID,Brenier‐Pinchart Marie‐Pierre¹,Touquet Bastien¹,Bertini Rose‐Laurence¹,Sensi Cristina²,Gay Gabrielle¹,Vollaire Julien³,Josserand Véronique³,Easom Eric⁴,Freund Yvonne R⁴,Pelloux Hervé¹,Rosenthal Philip J⁵,Cusack Stephen²,Hakimi Mohamed‐Ali¹^ORCID

Affiliation:

1. Institute for Advanced Biosciences (IAB) Team Host‐Pathogen Interactions & Immunity to Infection INSERM U1209 CNRS UMR 5309 Université Grenoble Alpes Grenoble France

2. European Molecular Biology Laboratory (EMBL) Grenoble Outstation and Unit of Virus Host‐Cell Interactions University of Grenoble‐EMBL‐Centre National de la Recherche Scientifique Grenoble Cedex 9 France

3. Institute for Advanced Biosciences (IAB) OPTIMAL Small Animal Imaging Facility Grenoble France

4. Anacor Pharmaceuticals Inc. Palo Alto CA USA

5. Department of Medicine University of California San Francisco CA USA

Funder

Labex

H2020 European Research Council

Agence Nationale de la Recherche

Publisher

EMBO

Subject

Molecular Medicine

Link